<qa>  What is an exception to this critiqu?17. Patient has had a prior monoclonal antibody within 4 weeks prior to study Day 1 or who has not recovered i.e., Grade 1 or at baseline from adverse events due to agents administered more than 4 weeks earlier. Subjects with Grade 2 neuropathy are an exception to this criterion and may qualify for the study. 